Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rhythm Pharmaceuticals Inc (NQ: RYTM )

20.65 USD +0.33 (+1.62%)
Official Closing Price Updated: 5:25 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 405,700
Open 20.32
Bid (Size) 19.90 (1)
Ask (Size) 22.67 (1)
Prev. Close 20.32
Today's Range 19.89 - 20.85
52wk Range 15.82 - 43.26
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
From GlobeNewswire News Releases
Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing Continued Weight Loss at Up to Nine Months in Patients with HET Obesity on Setmelanotide at ENDO 2021
From GlobeNewswire News Releases

Performance

YTD
-31.98%
-31.98%
1 Month
-21.84%
-21.84%
3 Month
-36.46%
-36.46%
6 Month
-18.60%
-18.60%
1 Year
+29.55%
+29.55%

More News

Read More
Rhythm Pharmaceuticals Announces Late-Breaking Data Presentations at ENDO 2021
From GlobeNewswire News Releases
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Rhythm Pharmaceuticals to Present at Cowen & Co. 41st Annual Health Care Conference
From GlobeNewswire News Releases
Rhythm Pharmaceuticals, Inc. Announces Closing of $172.5 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
From GlobeNewswire News Releases
7 Beaten Down Stocks with Significant Insider Buying
Tags WMPN CYTH RYTM
From InvestorPlace
We Did The Math LABU Can Go To $118
Tags ETFs
From ETF Channel
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
From GlobeNewswire News Releases
Top Buys by Directors: Meeker's $201.7K Bet on RYTM
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.